EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)

Hao Chi, Li Ma, Fanxing Zeng, Xiaolei Wang, Peng Peng, Xiaofei Bai, Ting Zhang, Wenhui Yin, Yaoyao Yu, Lingling Yang, Qingjun Zhou, Chao Wei und 1 weitere

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.2.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Hao Chi und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China. Hauptthemen laut MEDLINE: Graft Rejection, Corneal Transplantation, Aniline Compounds, Sulfonamides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Allograft rejection remains a major cause of failure in high-risk corneal transplants, but the underlying mechanisms are not fully understood. This study aimed to investigate the contribution of transplantation stress-induced cellular senescence to corneal allograft rejection and to elucidate the associated molecular mechanisms.

Methods

Age-matched murine corneal transplantation models were established. Cellular senescence was evaluated using senescence-associated β-galactosidase (SA-β-Gal) staining, western blot, and immunofluorescence staining. The role of cellular senescence in corneal allograft rejection was analyzed using p16 knockout mice and adoptive transfer experiments. Senolytic treatment with ABT-263 was administered intraperitoneally to evaluate its effects on corneal allograft rejection. RNA sequencing and pharmacological approaches were employed to identify the underlying mechanisms.

Results

Surgical injury induced a senescence-like phenotype in both donor corneas and recipient corneal beds, characterized by an increased accumulation of SA-β-Gal-positive cells in the corneal endothelium and stroma and elevated expression of senescence markers p16 and p21. Using genetic and adoptive transfer models, transplantation stress-induced senescence was shown to exacerbate corneal allograft rejection. Importantly, clearance of senescent cells by ABT-263 significantly suppressed ocular alloresponses and immune rejection. Mechanistically, RNA sequencing and loss-of-function experiments demonstrated that the anti-rejection effects of senolytic treatment were closely dependent on angiotensin-converting enzyme 2 (ACE2).

Conclusions

These findings highlight transplantation stress-induced senescence as a pivotal pathogenic factor in corneal allograft rejection. Senolytic therapy emerges as a potential novel strategy to mitigate transplant rejection and improve corneal allograft survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionCorneal TransplantationAniline CompoundsSulfonamidesPeptidyl-Dipeptidase AAnimalsMiceMice, Inbred C57BLDisease Models, AnimalCellular SenescenceMice, KnockoutUp-RegulationAllograftsBlotting, WesternMice, Inbred BALB CTransplantation, HomologousGraft SurvivalMale

Substanzen

Aniline CompoundsSulfonamidesnavitoclaxPeptidyl-Dipeptidase A

Autor:innen und Institutionen

  • State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China.
  • Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
  • School of Ophthalmology, Shandong First Medical University, Jinan, China.
  • Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Eye Institute of Shandong First Medical University, Jinan, China.
  • Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
  • https://orcid.org/0000-0003-1581-8377.

Zitieren

APA

Chi, H., Ma, L., Zeng, F., Wang, X., Peng, P., Bai, X., Zhang, T., Yin, W., Yu, Y., Yang, L., Zhou, Q., Wei, C., & Shi, W. (2025). Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.15

Vancouver

Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X, et al. Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.15

BibTeX
@article{Chi2025,
  author = {Chi, Hao and Ma, Li and Zeng, Fanxing and Wang, Xiaolei and Peng, Peng and Bai, Xiaofei and Zhang, Ting and Yin, Wenhui and Yu, Yaoyao and Yang, Lingling and Zhou, Qingjun and Wei, Chao and Shi, Weiyun},
  title = {Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.2.15}
}
Kostenlos starten →